|
Randomized Clinical Trial Finds No Mortality Risk or Benefit Associated with Drug-Coated Devices in the Treatment of Peripheral Artery Disease
|
|
Randomized Trial Reports Outcomes with Novel, Low Profile Fixed-Wire Drug-Eluting Stent that Facilitates Transradial Access
|
|
Randomized Trial Comparing a Nano-Coated Coronary Stent and Shorter DAPT Did Not Meet Non-Inferiority Criteria for Thrombotic Events
|
|
Randomized Trial Finds that Drug-Eluting Stents With Durable Polymers are Non-Inferior to Those With Biodegradable Polymers
|
|
OnSight Medical Wins TCT Connect 2020 hark Tank Innovation Competition
|
|
Deferral of PCI in FFR-Abnormal Lesions with Preserved Coronary Flow Reserve Is Not Associated with Similar Outcomes as Untreated Lesions with Normal FFR
|
|
Physiology-guided Percutaneous Coronary Intervention Optimization Strategy May Lead to Improved Outcomes
|
|
Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography Did Not Significantly Reduce Costs But Reduced Rates of Invasive Coronary Angiography
|
|
Trial Finds that Interventional Closure of Residual Atrial Septal Defect One-Month Post Transcatheter Mitral Valve Repair Was Not Superior to Medical Treatment
|
|
Randomized Trial Studies Device Designed to Reduce Embolic Events in Patients Undergoing TAVR
|
